Medipart Dispos. Xenon 133 Admin. Set Mp-0133M
510(k) K853576
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK853576 | Date7 Nov 1985 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- IYT
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.1390
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Medipart Disposable Xenon-133 Administration Set MP-0133M is a single-use, disposable system designed for the administration of Xenon-133, a radiopharmaceutical used in medical imaging. Classified as a rebreathing system for radionuclide imaging, it facilitates the inhalation of Xenon-133 gas to assess lung ventilation and perfusion, primarily in radiology applications. This device is intended for diagnostic purposes, enabling clinicians to evaluate lung function through non-invasive imaging techniques.
Supplied as a sterile, single-use disposable kit, the MP-0133M is intended for use in radiology settings where Xenon-133 imaging is required. The device is regulated under FDA 510(k) clearance (K853576) and falls under classification IYT, adhering to regulation 892.1390. It is not intended for MRI use and must be handled in compliance with radiopharmaceutical safety protocols. Storage and handling follow standard sterile disposable medical device guidelines, ensuring proper containment and disposal after single-use.
Other devices from Medipart Jerry Alexander
Questions
AI-generated answers, 1 Oct 2026
What is the Medipart Disposable Xenon-133 Administration Set MP-0133M used for?
The MP-0133M is a rebreathing system designed specifically for the administration of Xenon-133 gas, a radiopharmaceutical used in medical imaging. It enables clinicians to evaluate lung ventilation and perfusion through non-invasive inhalation imaging, primarily in radiology settings. This diagnostic tool helps assess lung function by allowing patients to inhale the gas, which is then detected to create detailed images of lung activity.
Is the MP-0133M sterile and single-use, or can it be reused?
The MP-0133M is supplied as a sterile, single-use disposable kit. This design ensures patient safety by preventing cross-contamination and maintaining sterility between uses. After a single procedure, the device must be discarded in accordance with radiopharmaceutical safety protocols and sterile disposable medical device guidelines.
What regulatory approval does the MP-0133M hold, and where is it classified?
The MP-0133M holds FDA 510(k) clearance under the reference number K853576, classified as substantially equivalent to a predicate device. It falls under the product code IYT and adheres to regulation 892.1390, which governs rebreathing systems for radionuclide imaging. This classification ensures it meets stringent safety and performance standards for diagnostic radiology applications.
Can the MP-0133M be used in MRI environments, or is it restricted to radiology?
The MP-0133M is explicitly designed for use in radiology settings and is not intended for MRI environments. Its primary purpose is the administration of Xenon-133 for lung ventilation and perfusion imaging, which requires compliance with radiopharmaceutical safety protocols. Using it in MRI settings could compromise imaging accuracy or patient safety.
How should the MP-0133M be stored and handled to maintain integrity?
The MP-0133M must be stored and handled as a sterile disposable medical device, following standard protocols for radiopharmaceutical administration sets. It should be kept in its original packaging until use to preserve sterility. After opening, it must be used immediately and discarded after a single procedure. Proper containment and disposal are critical to prevent contamination and ensure compliance with regulatory requirements.